Accredo Pharma Science Private Limited - Company Profile

It is a pharma private limited company based in Perambur Purasawalkam, Tamil Nadu, India, established in 2011.
2011 Perambur Purasawalkam, Tamil Nadu, India Active
Last Updated:
Access Report
About Accredo Pharma Science Private Limited

Accredo Pharma Science Private Limited, a active private limited company, was established on 30 December 2011 in Perambur Purasawalkam, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900TN2011PTC083825. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹1.96 Cr.

It upholds a compliant status. Employing 4 professional, Its leadership includes Chittibabu Sarathchandran (Additional Director), Jain Arihant Kumar Narendrakumar (Managing Director), Subramanian Murali (Whole-Time Director). Past directors included Richard Jeyaseelan, Chittibabu Sarathchandran, Jain Arihant Kumar Narendrakumar. It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New No. 14, Old No. 25/1, J Block, Perambur Purasawalkam, Tamil Nadu, 600102.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900TN2011PLC083825

  • Registration Number

    083825

  • Incorporation Date

    30 December 2011

  • Authorized Capital

    ₹11.00 Cr

  • Paid-Up Capital

    ₹1.96 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 1.96 Cr
  • Company Age 14 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 10.00 Cr
  • Revenue Growth **** 16.11%
  • Profit Growth **** -31.58%
  • Ebitda **** -60.19%
  • Net Worth 22.28%
  • Total Assets -30.58%
Company report

Accredo Pharma Science Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Accredo Pharma Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Accredo Pharma Science Private Limited?
Current Directors
Name Designation Appointment Date Status
Chittibabu Sarathchandran Additional Director 08 May 2015 Current
Jain Arihant Kumar Narendrakumar Managing Director 08 May 2015 Current
Subramanian Murali Whole-Time Director 11 Oct 2021 Current
Siroya Rajeshkumar Director 27 Mar 2018 Current
Soniya Jain Additional Director 16 Apr 2025 Current
Anil Sharma Additional Director 20 Nov 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2020 Past
Pramod Abcsdd Additional Director 27 Mar 2018 Past
Pramod Abcsdd Additional Director 29 Sep 2022 Past
Pramod Abcsdd Director 08 May 2015 Past
Pramod Abcsdd Director 18 Dec 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Accredo Pharma Science.

Accredo Pharma Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.11% increase. The company also saw a substantial fall in profitability, with a 31.58% decrease in profit. The company's net worth Soared by an impressive increase of 22.28%.

Accredo Pharma Science revenue growth over time
Accredo Pharma Science profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 16.11%
*******
*******
*******
*******
Revenue from Operations
*******
 14.07%
*******
*******
*******
*******
Total Assets
*******
 -30.58%
*******
*******
*******
*******
Profit or Loss
*******
 -31.58%
*******
*******
*******
*******
Net Worth
*******
 22.28%
*******
*******
*******
*******
EBITDA
*******
 -60.19%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Accredo Pharma Science?

In 2023, Accredo Pharma Science had a public holding of 21.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹100,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 10.00 Cr
Latest Charge Details
Date Lender Amount Status
01 Feb 2021 Others ₹10.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Accredo Pharma Science?

Accredo Pharma Science has a workforce of 4 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Accredo Pharma Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accredo Pharma Science's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Accredo Pharma Science
Recent Activity within the Organization
  • Director Appointment

    Ranganathan Kuppan was appointed as a Cfo was appointed as a Cfo on 13 Dec 2025 & has been associated with this company since 4 months 29 days . was recorded as a recent event.

  • Director Appointment

    The activity Anil Sharma was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2025 & has been associated with this company since 5 months 21 days . was completed.

  • Director Appointment

    The activity Meenakshisundaram Kolandaivel was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2025 & has been associated with this company since 5 months 21 days . was completed.

  • Charges

    Progress on A charge with Others of Rs. 10.00 Cr registered on 01 Feb 2021 with Charge ID 100436450 was modified on 25 Aug 2025. was documented.

  • Director Appointment

    Progress on Soniya Jain was appointed as a Additional Director was appointed as a Additional Director on 16 Apr 2025 & has been associated with this company since 1 year 25 days . was documented.

  • Annual General Meeting

    Accredo Pharma Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Accredo Pharma Science Private Limited?

The CIN of Accredo Pharma Science Private Limited is U74900TN2011PLC083825.

Where is Accredo Pharma Science Private Limited headquartered?

Accredo Pharma Science Private Limited is headquartered at New No. 14, Old No. 25/1, J Block, Perambur Purasawalkam, Tamil Nadu, 600102.

When was Accredo Pharma Science Private Limited incorporated?

Accredo Pharma Science Private Limited was incorporated on 30 December 2011.

Who are the current directors of Accredo Pharma Science Private Limited?

The current directors of Accredo Pharma Science Private Limited are

What is the primary industry of Accredo Pharma Science Private Limited?

The primary industry of Accredo Pharma Science Private Limited is Trade.

Is Accredo Pharma Science Private Limited a listed company?

Accredo Pharma Science Private Limited is unlisted.

What is the capital structure of Accredo Pharma Science Private Limited?

The authorized capital of Accredo Pharma Science Private Limited is ₹11.00 Cr, and the paid-up capital is ₹1.96 Cr.

What is the compliance status of Accredo Pharma Science Private Limited?

The compliance status of Accredo Pharma Science Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available